These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 1579898

  • 1. Blood platelet function in canine acute pancreatitis with reference to treatment with Nafamostat mesilate (FUT-175).
    Lukaszyk A, Bodzenta-Lukaszyk A, Gabryelewicz A, Bielawiec M.
    Thromb Res; 1992 Jan 15; 65(2):229-39. PubMed ID: 1579898
    [Abstract] [Full Text] [Related]

  • 2. Effect of FUT-175 (nafamstat mesilate) on platelets in canine acute experimental pancreatitis.
    Gabryelewicz A, Prokopowicz J, Bodzenta A, Bielecki W, Rydzewska G.
    Digestion; 1988 Jan 15; 40(1):19-24. PubMed ID: 3234615
    [Abstract] [Full Text] [Related]

  • 3. Does acute experimental pancreatitis affect blood platelet function?
    Lukaszyk A, Bodzenta-Lukaszyk A, Gabryelewicz A, Bielawiec M.
    Thromb Res; 1989 Feb 01; 53(3):319-25. PubMed ID: 2524119
    [Abstract] [Full Text] [Related]

  • 4. Pharmacological studies of FUT-175, nafamostat mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats.
    Iwaki M, Ino Y, Motoyoshi A, Ozeki M, Sato T, Kurumi M, Aoyama T.
    Jpn J Pharmacol; 1986 Jun 01; 41(2):155-62. PubMed ID: 2427760
    [Abstract] [Full Text] [Related]

  • 5. [Pharmacokinetics studies of nafamostat mesilate (FUT), a synthetic protease inhibitor, which has been used for the treatments of DIC and acute pancreatitis, and as an anticoagulant in extracorporeal circulation].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 2000 May 01; 27(5):767-74. PubMed ID: 10832450
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Molecular specificity of nafamostat mesilate (FUT), a drug used for the treatments of DIC and acute pancreatitis and as an anticoagulant--the pharmacodynamics and pharmacological action].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 2001 Sep 01; 28(9):1237-43. PubMed ID: 11579633
    [Abstract] [Full Text] [Related]

  • 9. Effects of nafamostat mesilate on the prevention of cerulein-induced acute pancreatitis.
    Lee JK, Ryu JK, Park JK, Lee SH, Yoon WJ, Kim YT, Jung HC, Yoon YB.
    Pancreas; 2008 Apr 01; 36(3):255-60. PubMed ID: 18362838
    [Abstract] [Full Text] [Related]

  • 10. Effect of a synthetic protease inhibitor (Fut-175) on coagulation abnormalities during experimental acute pancreatitis in dogs.
    Satake K, Ha S, Hiura A, Nishiwaki H, Haku A, Umeyama K.
    Gastroenterol Jpn; 1990 Dec 01; 25(6):720-6. PubMed ID: 2279634
    [Abstract] [Full Text] [Related]

  • 11. [Pharmacological studies of FUT-175, nafamstat mesilate. II. Effects on experimental acute pancreatitis].
    Iwaki M, Ozeki M, Sato T, Suzuki K, Motoyoshi A, Suzuki S, Fujita M, Aoyama T.
    Nihon Yakurigaku Zasshi; 1984 Oct 01; 84(4):363-72. PubMed ID: 6210233
    [Abstract] [Full Text] [Related]

  • 12. Nafamostat mesilate on the course of acute pancreatitis. Protective effect on peritoneal permeability and relation with supervening pulmonary distress.
    Marotta F, Fesce E, Rezakovic I, Chui DH, Suzuki K, Idéo G.
    Int J Pancreatol; 1994 Aug 01; 16(1):51-9. PubMed ID: 7528762
    [Abstract] [Full Text] [Related]

  • 13. Synthetic antiproteases in acute pancreatitis: an experimental study.
    Dobosz M, Sledziński Z, Babicki A, Juszkiewicz P, Basiński A, Wajda Z.
    Mt Sinai J Med; 1992 Jan 01; 59(1):43-6. PubMed ID: 1734237
    [Abstract] [Full Text] [Related]

  • 14. The effects of nafamostat mesilate (FUT-175) on caerulein-induced acute pancreatitis in the rat.
    Wisner JR, Ozawa S, Renner IG.
    Int J Pancreatol; 1989 May 01; 4(4):383-90. PubMed ID: 2732529
    [Abstract] [Full Text] [Related]

  • 15. [The inhibitory effect of nafamostat mesilate (FUT-175) on liver metastasis].
    Kimura T, Fuchimoto S, Iwagaki H, Orita K.
    Nihon Geka Gakkai Zasshi; 1993 Jan 01; 94(1):66-70. PubMed ID: 8437554
    [Abstract] [Full Text] [Related]

  • 16. The effect of nafamostat mesilate (FUT-175) and gabexate mesilate (FOY) on multiorgan oxidant-antioxidant balance in acute experimental pancreatitis.
    Dabrowski A, Gabryelewicz A.
    J Physiol Pharmacol; 1994 Sep 01; 45(3):455-65. PubMed ID: 7841457
    [Abstract] [Full Text] [Related]

  • 17. Nafamostat mesilate modulates the release of platelet-activating factor during left ventricular assistance with hemofiltration in canine heart failure.
    Munakata M, Ono Y, Koyama M, Fukui K, Satoh K, Suzuki S.
    Jpn J Thorac Cardiovasc Surg; 2000 Feb 01; 48(2):106-11. PubMed ID: 10769990
    [Abstract] [Full Text] [Related]

  • 18. [Effect of continuous arterial infusion of protease inhibitor on experimental acute pancreatitis induced by closed duodenal loop obstruction].
    Kakugawa Y, Takeda K, Sunamura M, Kawaguchi S, Kobari M, Matsuno S.
    Nihon Shokakibyo Gakkai Zasshi; 1990 Jun 01; 87(6):1444-50. PubMed ID: 2214268
    [Abstract] [Full Text] [Related]

  • 19. Platelet function in experimentally induced pancreatitis in the dog.
    Jacobs RM, Murtaugh RJ, Fertel RH.
    Thromb Haemost; 1986 Apr 30; 55(2):197-200. PubMed ID: 3087002
    [Abstract] [Full Text] [Related]

  • 20. [The protease inhibitor gabexate mesilate in experimentally-induced acute pancreatitis with early gram-negative infection in the Göttingen minipig: therapeutic efficacy and effects on blood coagulation and fibrinolysis].
    Heitz J, Semsch B, Emde C, Jansen U, Schäfer JH.
    Z Gastroenterol; 1990 Apr 30; 28(4):192-7. PubMed ID: 2119091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.